VECTIV
Vectiv provides enterprise store lifecycle management solutions that enable retail companies to align their stores with their customer base. Its solutions are able to manage and execute activities related to rolling out new stores; and changing formats, relocating, and closing of existing stores. Vectiv was acquired by Accruent in February 2003. Vectiv was founded in 1999 and is based in San Francisco, California.
VECTIV
Industry:
Application Performance Management Information Technology Web Hosting
Founded:
1999-01-01
Address:
San Francisco, California, United States
Country:
United States
Total Employee:
1+
Status:
Active
Contact:
(415)626-2211
Total Funding:
8.1 M USD
Similar Organizations
Intersessions
Intersessions offers web application hosting services and e-commerce solutions services.
Kadiri
Kadiri offers a web-based solution that aims to support enterprise-wide compensation management.
Investors List
Campsix
Campsix investment in Venture Round - Vectiv
Convergence Partners
Convergence Partners investment in Venture Round - Vectiv
More informations about "Vectiv"
Home | VECTIV
Vectiv is a leading IT consulting and services firm. Vectiv specializes in IT services, custom application development and healthcare technology services.See details»
About Us | VECTIV
Vectiv is a leading IT consulting and services firm. Vectiv specializes in IT services, custom application development and healthcare technology services.See details»
Experience VECTIV TM - The North Face
From ultra races to your local trails, day hikes to overnight treks, Vectiv TM technology is engineered for every foot and every trail. Discover our full range. Find your perfect fit.See details»
VectivBio - Crunchbase Company Profile & Funding
VectivBio is a clinical-stage biotechnology company bringing transformational medicines to patients with serious rare diseases. They are committed to pursuing rare diseases with well-defined biology that can be targeted with best-in …See details»
Ironwood Pharmaceuticals, Inc. - Ironwood Enters into Definitive ...
May 22, 2023 · Headquartered in Basel, Switzerland, VectivBio is a clinical-stage biotechnology company focused on the discovery and development of treatments for severe, rare conditions, …See details»
VectivBio Company Profile 2024: Valuation, Investors
VectivBio Holding AG is a clinical stage biopharmaceutical company. It is focused on the discovery, development and commercialization of innovative treatments for severe rare conditions for which there is a significant unmet medical need.See details»
VectivBio to be Acquired by Ironwood - Cooley
Basel, Switzerland – May 23, 2023 – Cooley advised VectivBio, a clinical-stage biotech company focused on the discovery and development of treatments for severe, rare gastrointestinal (GI) …See details»
Vectiv - Crunchbase Company Profile & Funding
Vectiv provides enterprise store lifecycle management solutions that enable retail companies to align their stores with their customer base. Its solutions are able to manage and execute …See details»
VectivBio Closes $110 Million Crossover Financing to Advance ...
Oct 15, 2020 · VectivBio is a global, clinical-stage biotechnology company focused on developing transformational therapeutics for patients living with serious, rare diseases.See details»
VECTIV™ Technology | The North Face Canada
Our proprietary VECTIV technology minimizes the impact of each stride, with no compromise on energy efficiency. The Flight VECTIV shoe has been proven by third-party research to reduce tibial stresses by over 10%.See details»
VectivBio Announces Pricing of Initial Public Offering
Apr 9, 2021 · The gross proceeds to Vectiv, before deducting underwriting discounts and commissions and offering expenses, are expected to be $127.5 million. All of the ordinary …See details»
VECTIV™ Trail Running Shoes | The North Face
From ultra races to your local trails, day hikes to overnight treks, The North Face VECTIV™ shoes are engineered for every foot and every trail. Discover why VECTIV™ technology is the …See details»
VectivBio Announces Pricing of Initial Public Offering
Sep 4, 2021 · The gross proceeds to Vectiv, before deducting underwriting discounts and commissions and offering expenses, are expected to be $127.5 million. All of the ordinary …See details»
VectivBio Announces Pricing of $125 Million Underwritten …
BASEL, Switzerland, Oct. 13, 2022 (GLOBE NEWSWIRE) -- VectivBio Holding AG (“VectivBio”) (Nasdaq: VECT), a clinical-stage biopharmaceutical company pioneering novel …See details»
VectivBio Announces Closing of $146.6 Million Initial Public Offering
Apr 14, 2021 · VectivBio (Nasdaq: VECT) is a global, clinical-stage biotechnology company focused on the discovery, development and commercialization of innovative treatments for …See details»
VectivBio - Funding, Financials, Valuation & Investors - Crunchbase
VectivBio is a biotechnology company committed to making innovative treatments for patients suffering from serious rare diseases.See details»
VectivBio - Contacts, Employees, Board Members, Advisors & Alumni
VectivBio is a biotechnology company committed to making innovative treatments for patients suffering from serious rare diseases.See details»
VectivBio Announces Closing of $54 Million Aggregate
BASEL, Switzerland, June 29, 2022 (GLOBE NEWSWIRE) -- VectivBio Holding AG (“VectivBio”) (Nasdaq: VECT), a clinical-stage biopharmaceutical company pioneering novel …See details»
VectivBio Reports Full Year 2021 Financial Results and Provides ...
BASEL, Switzerland, April 07, 2022 (GLOBE NEWSWIRE) -- VectivBio Holding AG (“VectivBio”) (Nasdaq: VECT), a clinical-stage biopharmaceutical company pioneering novel …See details»
The North Face’s New Running Shoe Is the First of Its Kind
Jan 30, 2021 · Its first major launch of 2021 is Vectiv, a new trail footwear system that relies on the same plate-propelled design idea that’s swept over the premium road running shoe …See details»